Bone Sci Bio

Bone Sci Bio is an Israeli private medtech/biotech company developing peptide-enhanced bone repair and local drug-delivery products for orthopedic and dental applications. Its lead platform, PeptOss, is designed as a drug-device combination that both promotes bone regeneration and enables controlled local delivery of therapeutics directly into bone defects. The company has highlighted initial applications in peri-implantitis, with longer-term potential in orthopedic repair, osteoporosis-related bone strengthening, and bone oncology applications. Bone Sci Bio appears to be an early-stage, preclinical company commercializing technology originating from Ben-Gurion University of the Negev.